{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:04:58Z","timestamp":1790827498367,"version":"4.1.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00203-025-04252-z","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:22:10Z","timestamp":1739463730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mechanisms, therapeutic strategies, and emerging therapeutic alternatives for carbapenem resistance in Gram-negative bacteria"],"prefix":"10.1007","volume":"207","author":[{"given":"Fatima","family":"Mourabiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimazahra","family":"Jouga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souraya","family":"Sakoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otmane","family":"El Hosayny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Zouheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaziz","family":"Soukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"El Khalfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"4252_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7120415","author":"U Abubakar","year":"2022","unstructured":"Abubakar U, Zulkarnain AI, Rodr\u00edguez-Ba\u00f1o J, Kamarudin N, Elrggal ME, Elnaem MH, Harun SN (2022) Treatments and predictors of mortality for carbapenem-resistant gram-negative bacilli infections in malaysia: a retrospective cohort study. Trop Med Infect Dis. https:\/\/doi.org\/10.3390\/tropicalmed7120415","journal-title":"Trop Med Infect Dis"},{"key":"4252_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13213-020-01579-4","volume":"70","author":"AA Adegoke","year":"2020","unstructured":"Adegoke AA, Fatunla OK, Okoh AI (2020) Critical threat associated with carbapenem-resistant gram-negative bacteria: prioritizing water matrices in addressing total antibiotic resistance. Ann Microbiol 70:43","journal-title":"Ann Microbiol"},{"key":"4252_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2024.100351","author":"FA Afify","year":"2024","unstructured":"Afify FA, Shata AH, Aboelnaga N, Osama D, Elsayed SW, Saif NA, Mouftah SF, Shawky SM, Mohamed AA, Loay O, Elhadidy M (2024) Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: a cross sectional study to assess resistance trends during the COVID-19 pandemic. J Genetic Eng Biotechnol. https:\/\/doi.org\/10.1016\/j.jgeb.2024.100351","journal-title":"J Genetic Eng Biotechnol"},{"key":"4252_CR4","doi-asserted-by":"publisher","first-page":"116833","DOI":"10.1016\/j.ejmech.2024.116833","volume":"279","author":"M Aggarwal","year":"2024","unstructured":"Aggarwal M, Patra A, Awasthi I, George A, Gagneja S, Gupta V, Capalash N, Sharma P (2024) Drug repurposing against antibiotic resistant bacterial pathogens. Eur J Med Chem 279:116833","journal-title":"Eur J Med Chem"},{"key":"4252_CR5","doi-asserted-by":"publisher","first-page":"105833","DOI":"10.1016\/j.ijantimicag.2019.10.014","volume":"55","author":"AA Agyeman","year":"2020","unstructured":"Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB (2020) A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents 55:105833","journal-title":"Int J Antimicrob Agents"},{"key":"4252_CR6","doi-asserted-by":"publisher","first-page":"859854","DOI":"10.3389\/fmicb.2022.859854","volume":"13","author":"S Algarni","year":"2022","unstructured":"Algarni S, Ricke SC, Foley SL, Han J (2022) The dynamics of the antimicrobial resistance mobilome of salmonella enterica and related enteric bacteria. Front Microbiol 13:859854","journal-title":"Front Microbiol"},{"key":"4252_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020854","author":"SF Ali","year":"2024","unstructured":"Ali SF, Teh SH, Yang HH, Tsai YC, Chao HJ, Peng SS, Chen SC, Lin LC, Lin NT (2024) Therapeutic potential of a novel lytic phage, vB_EclM_ECLFM1, against carbapenem-resistant Enterobacter cloacae. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25020854","journal-title":"Int J Mol Sci"},{"key":"4252_CR8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/jac\/dku568","volume":"70","author":"RA Alm","year":"2014","unstructured":"Alm RA, Johnstone MR, Lahiri SD (2014) Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam\/avibactam: role of a novel insertion in PBP3. J Antimicrob Chemother 70:1420\u20131428. https:\/\/doi.org\/10.1093\/jac\/dku568","journal-title":"J Antimicrob Chemother"},{"key":"4252_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01699","author":"R Al-Mutairi","year":"2018","unstructured":"Al-Mutairi R, Tovmasyan A, Batinic-Haberle I, Benov L (2018) Sublethal photodynamic treatment does not lead to development of resistance. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.01699","journal-title":"Front Microbiol"},{"key":"4252_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00805","author":"M Annamanedi","year":"2017","unstructured":"Annamanedi M, Varma GYN, Anuradha K, Kalle AM (2017) Celecoxib enhances the efficacy of low-dose antibiotic treatment against polymicrobial sepsis in mice and clinical isolates of ESKAPE pathogens. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2017.00805","journal-title":"Front Microbiol"},{"key":"4252_CR11","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001462","author":"T Armstrong","year":"2021","unstructured":"Armstrong T, Fenn SJ, Hardie KR (2021) JMM profile: carbapenems: a broad-spectrum antibiotic. J Med Microbiol. https:\/\/doi.org\/10.1099\/jmm.0.001462","journal-title":"J Med Microbiol"},{"key":"4252_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, Barbarisi A, Passavanti MB, Pace MC (2022) Mechanisms of action of carbapenem resistance. Antibiotics 11:421","journal-title":"Antibiotics"},{"key":"4252_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012187","author":"Y Bai","year":"2024","unstructured":"Bai Y, Xie C, Zhang Y, Zhang Z, Liu J, Cheng G, Li Y, Wang D, Cui B, Liu Y, Qin X (2024) sRNA expression profile of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae: functional role of sRNA51. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1012187","journal-title":"PLoS Pathog"},{"key":"4252_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01760-22","author":"K Banerjee","year":"2022","unstructured":"Banerjee K, Motley MP, Boniche-Alfaro C, Bhattacharya S, Shah R, Ardizzone A, Fries BC (2022) Patient-derived antibody data yields development of broadly cross-protective monoclonal antibody against ST258 carbapenem-resistant klebsiella pneumoniae. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.01760-22","journal-title":"Microbiol Spectr"},{"key":"4252_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10070767","author":"M Bartolomeu","year":"2021","unstructured":"Bartolomeu M, Oliveira C, Pereira C, Neves MGPMS, Faustino MAF, Almeida A (2021) Antimicrobial photodynamic approach in the inactivation of viruses in wastewater: Influence of alternative adjuvants. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics10070767","journal-title":"Antibiotics"},{"issue":"5","key":"4252_CR16","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00253-018-8776-0","volume":"102","author":"A Bassegoda","year":"2018","unstructured":"Bassegoda A, Ivanova K, Ramon E, Tzanov T (2018) Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials. Appl Microbiol Biotechnol 102(5):2075\u20132089","journal-title":"Appl Microbiol Biotechnol"},{"key":"4252_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics","author":"P Behzadi","year":"2021","unstructured":"Behzadi P, Bar\u00e1th Z, Gajd\u00e1cs M (2021) It\u2019s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant pseudomonas aeruginosa. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics","journal-title":"Antibiotics"},{"key":"4252_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/antibiotics13080783","volume":"13","author":"MC Bellucci","year":"2024","unstructured":"Bellucci MC, Romani C, Sani M, Volonterio A (2024) Dual antibiotic approach: synthesis and antibacterial activity of antibiotic-antimicrobial peptide conjugates. Antibiotics 13:783","journal-title":"Antibiotics"},{"key":"4252_CR19","doi-asserted-by":"publisher","first-page":"13165","DOI":"10.3390\/molecules200713165","volume":"20","author":"FA Bernal","year":"2015","unstructured":"Bernal FA, Coy-Barrera E (2015) Molecular docking and multivariate analysis of xanthones as antimicrobial and antiviral agents. Molecules 20:13165\u201313204. https:\/\/doi.org\/10.3390\/molecules200713165","journal-title":"Molecules"},{"key":"4252_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41489-3","author":"S Bharathan","year":"2019","unstructured":"Bharathan S, Sundaramoorthy NS, Chandrasekaran H, Rangappa G, ArunKumar GP, Subramaniyan SB, Veerappan A, Nagarajan S (2019) Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-41489-3","journal-title":"Sci Rep"},{"key":"4252_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.trsl.2020.02.008","volume":"220","author":"T Brennan-Krohn","year":"2020","unstructured":"Brennan-Krohn T, Manetsch R, O\u2019Doherty GA, Kirby JE (2020) New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae. Transl Res 220:14\u201332","journal-title":"Transl Res"},{"key":"4252_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","author":"K Bush","year":"2016","unstructured":"Bush K, Bradford PA (2016) \u03b2-lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a025247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4252_CR23","first-page":"273","volume-title":"Methods in molecular biology","author":"R Byrne","year":"2019","unstructured":"Byrne R, Schneider G (2019) In silico target prediction for small molecules. Methods in molecular biology. Humana Press Inc., Totowa, pp 273\u2013309"},{"key":"4252_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/plants6020016","volume":"6","author":"H Chandra","year":"2017","unstructured":"Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AP, Nautiyal AR (2017) Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials\u2014a review. Plants 6:457\u2013462","journal-title":"Plants"},{"key":"4252_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05173-7","author":"C Chen","year":"2023","unstructured":"Chen C, Cai J, Shi J, Wang Z, Liu Y (2023) Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-023-05173-7","journal-title":"Commun Biol"},{"key":"4252_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jgar.2021.03.024","volume":"25","author":"Z Cherak","year":"2021","unstructured":"Cherak Z, Loucif L, Moussi A, Rolain JM (2021) Carbapenemase-producing Gram-negative bacteria in aquatic environments: a review. J Glob Antimicrob Resist 25:287\u2013309","journal-title":"J Glob Antimicrob Resist"},{"key":"4252_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jmii.2016.12.005","volume":"50","author":"PY Chung","year":"2017","unstructured":"Chung PY, Khanum R (2017) Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. J Microbiol Immunol Infect 50:405\u2013410","journal-title":"J Microbiol Immunol Infect"},{"key":"4252_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz344","author":"CJ Clancy","year":"2019","unstructured":"Clancy CJ, Potoski BA, Buehrle D, Nguyen MH (2019) Estimating the treatment of carbapenem-resistant enterobacteriaceae infections in the united states using antibiotic prescription data. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofz344","journal-title":"Open Forum Infect Dis"},{"key":"4252_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/2049936120952604","author":"JA Clark","year":"2020","unstructured":"Clark JA, Burgess DS (2020) Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance. Ther Adv Infect Dis. https:\/\/doi.org\/10.1177\/2049936120952604","journal-title":"Ther Adv Infect Dis"},{"key":"4252_CR30","first-page":"1","volume":"6","author":"FS Codjoe","year":"2017","unstructured":"Codjoe FS, Donkor ES (2017) Carbapenem resistance: a review. Med Sci (Basel) 6:1","journal-title":"Med Sci (Basel)"},{"key":"4252_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/15592294.2020.1748918","volume":"15","author":"E Crimi","year":"2020","unstructured":"Crimi E, Benincasa G, Cirri S, Mutesi R, Faenza M, Napoli C (2020) Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness. Epigenetics 15:1021\u20131034","journal-title":"Epigenetics"},{"key":"4252_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jcpt.13149","volume":"45","author":"TF da Rosa","year":"2020","unstructured":"da Rosa TF, Coelho SS, Foletto VS, Bottega A, Serafin MB, Machado CS, Franco LN, de Paula BR, H\u00f6rner R (2020) Alternatives for the treatment of infections caused by ESKAPE pathogens. J Clin Pharm Ther 45:863\u2013873","journal-title":"J Clin Pharm Ther"},{"key":"4252_CR33","doi-asserted-by":"publisher","first-page":"104628","DOI":"10.1016\/j.idnow.2022.09.023","volume":"53","author":"S Das","year":"2023","unstructured":"Das S (2023) The crisis of carbapenemase-mediated carbapenem resistance across the human\u2013animal\u2013environmental interface in India. Infect Dis Now 53:104628","journal-title":"Infect Dis Now"},{"key":"4252_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010334","author":"S David","year":"2022","unstructured":"David S, Wong JLC, Sanchez-Garrido J, Kwong HS, Low WW, Morecchiato F, Giani T, Rossolini GM, Brett SJ, Clements A, Beis K, Aanensen DM, Frankel G (2022) Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1010334","journal-title":"PLoS Pathog"},{"key":"4252_CR35","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1128\/AAC.03042-15","volume":"60","author":"BLM De Jonge","year":"2016","unstructured":"De Jonge BLM, Karlowsky JA, Kazmierczak KM, Biedenbach DJ, Sahm DF, Nichols WW (2016) In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014). Antimicrob Agents Chemother 60:3163\u20133169. https:\/\/doi.org\/10.1128\/AAC.03042-15","journal-title":"Antimicrob Agents Chemother"},{"key":"4252_CR36","doi-asserted-by":"publisher","first-page":"10757","DOI":"10.1021\/acsomega.3c00312","volume":"8","author":"G Dhanda","year":"2023","unstructured":"Dhanda G, Acharya Y, Haldar J (2023) Antibiotic adjuvants: a versatile approach to combat antibiotic resistance. ACS Omega 8:10757\u201310783","journal-title":"ACS Omega"},{"key":"4252_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3314\/jnhrc.v19i1.3282","volume":"19","author":"G Dhungana","year":"2021","unstructured":"Dhungana G, Regmi M, Paudel P, Parajuli A, Upadhyay E, Gyawali I, Upreti H, Nepal R, Pradhan P, Malla R (2021) Therapeutic efficacy of bacteriophage therapy to treat carbapenem resistant klebsiella pneumoniae in mouse model. J Nepal Health Res Counc 19:76\u201382. https:\/\/doi.org\/10.3314\/jnhrc.v19i1.3282","journal-title":"J Nepal Health Res Counc"},{"key":"4252_CR38","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi Y (2019) Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis 69:S565\u2013S575. https:\/\/doi.org\/10.1093\/cid\/ciz830","journal-title":"Clin Infect Dis"},{"key":"4252_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101281","author":"M Douglas","year":"2023","unstructured":"Douglas M, Heithoff LBV, Mahan SP, Fried JC, Fitzgibbons LN, House JK, Maha MJ (2023) Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood. Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101281","journal-title":"Cell Rep Med"},{"key":"4252_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12088-024-01293-8","volume":"64","author":"S Dubey","year":"2024","unstructured":"Dubey S, Siddiqui AH, Sharma M (2024) The impact of fosfomycin on gram negative infections: a comprehensive review. Indian J Microbiol 64:846\u2013858","journal-title":"Indian J Microbiol"},{"key":"4252_CR41","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.2147\/IDR.S259562","volume":"13","author":"O Dziri","year":"2020","unstructured":"Dziri O, Dziri R, El Salabi AA, Chouchani C (2020) Carbapenemase producing gram-negative bacteria in Tunisia: history of thirteen years of challenge. Infect Drug Resist 13:4177\u20134191","journal-title":"Infect Drug Resist"},{"key":"4252_CR42","doi-asserted-by":"publisher","first-page":"S559","DOI":"10.1093\/cid\/ciz829","volume":"69","author":"R Echols","year":"2019","unstructured":"Echols R, Ariyasu M, Den NT (2019) Pathogen-focused clinical development to address unmet medical need: cefiderocol targeting carbapenem resistance. Clin Infect Dis 69:S559\u2013S564. https:\/\/doi.org\/10.1093\/cid\/ciz829","journal-title":"Clin Infect Dis"},{"key":"4252_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00933","author":"B El Hafi","year":"2019","unstructured":"El Hafi B, Rasheed SS, Abou Fayad AG, Araj GF, Matar GM (2019) Evaluating the efficacies of carbapenem\/\u03b2-lactamase inhibitors against carbapenem-resistant gram-negative bacteria in vitro and in vivo. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.00933","journal-title":"Front Microbiol"},{"key":"4252_CR44","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0098","author":"AA Elshamy","year":"2020","unstructured":"Elshamy AA, Aboshanab KM (2020) A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Sci OA. https:\/\/doi.org\/10.2144\/fsoa-2019-0098","journal-title":"Future Sci OA"},{"key":"4252_CR45","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.3390\/molecules26175124","volume":"26","author":"S Galati","year":"2021","unstructured":"Galati S, Di Stefano M, Martinelli E, Poli G, Tuccinardi T (2021) Recent advances in in silico target fishing. Molecules 26:5124","journal-title":"Molecules"},{"key":"4252_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117666","author":"P Garc\u00eda","year":"2024","unstructured":"Garc\u00eda P, Guijarro-S\u00e1nchez P, Lasarte-Monterrubio C, Muras A, Alonso-Garc\u00eda I, Outeda-Garc\u00eda M, Maceiras R, del Fern\u00e1ndez-L\u00f3pez MC, Rodr\u00edguez-Coello A, Garc\u00eda-Pose A, Blanco-Mart\u00edn T, Gonz\u00e1lez-Pinto L, Arca-Su\u00e1rez J, V\u00e1zquez-Ucha JC, Bou G, Beceiro A (2024) Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.117666","journal-title":"Biomed Pharmacother"},{"key":"4252_CR47","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","volume":"41","author":"J Garnacho-Montero","year":"2015","unstructured":"Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M (2015) Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med 41:2057\u20132075. https:\/\/doi.org\/10.1007\/s00134-015-4079-4","journal-title":"Intensive Care Med"},{"key":"4252_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cbdd.12478","volume":"85","author":"EE Gill","year":"2015","unstructured":"Gill EE, Franco OL, Hancock REW (2015) Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. Chem Biol Drug des 85:56\u201378. https:\/\/doi.org\/10.1111\/cbdd.12478","journal-title":"Chem Biol Drug des"},{"key":"4252_CR49","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1093\/jac\/dkae203","volume":"79","author":"KA Glen","year":"2024","unstructured":"Glen KA, Lamont IL (2024) Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to \u03b2-lactams but inhibit cell division. J Antimicrob Chemother 79:2170\u20132178. https:\/\/doi.org\/10.1093\/jac\/dkae203","journal-title":"J Antimicrob Chemother"},{"key":"4252_CR50","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/jac\/dkaa206","volume":"75","author":"MA Gomis-Font","year":"2020","unstructured":"Gomis-Font MA, Cabot G, S\u00e1nchez-Diener I, Fraile-Ribot PA, Juan C, Moya B, Zamorano L, Oliver A (2020) In vitro dynamics and mechanisms of resistance development to imipenem and imipenem\/relebactam in Pseudomonas aeruginosa. J Antimicrob Chemother 75:2508\u20132515. https:\/\/doi.org\/10.1093\/jac\/dkaa206","journal-title":"J Antimicrob Chemother"},{"key":"4252_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10112283","author":"AJ Gondal","year":"2022","unstructured":"Gondal AJ, Choudhry N, Bukhari H, Rizvi Z, Yasmin N (2022) Characterization of genomic diversity among carbapenem-resistant Escherichia coli clinical isolates and antibacterial efficacy of silver nanoparticles from Pakistan. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10112283","journal-title":"Microorganisms"},{"key":"4252_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106049","author":"M Gopikrishnan","year":"2023","unstructured":"Gopikrishnan M, George Priya Doss C (2023) Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2023.106049","journal-title":"Microb Pathog"},{"key":"4252_CR53","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.3390\/jcm11123258","volume":"11","author":"G Granata","year":"2022","unstructured":"Granata G, Taglietti F, Schiavone F, Petrosillo N (2022) Durlobactam in the treatment of multidrug-resistant acinetobacter baumannii infections: a systematic review. J Clin Med 11:3258","journal-title":"J Clin Med"},{"key":"4252_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12071353","author":"J Halim","year":"2024","unstructured":"Halim J, Carr RA, Fliorent R, Jonnalagadda K, Kurbonnazarova M, Kaur M, Millstein I, Carabetta VJ (2024) Combinations of antibiotics effective against extensively- and pandrug-resistant acinetobacter baumannii patient isolates. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms12071353","journal-title":"Microorganisms"},{"key":"4252_CR55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01836-19","author":"J Huang","year":"2020","unstructured":"Huang J, Hu X, Zhao Y, Shi Y, Ding H, Xv J, Ren J, Wu R, Zhao Z (2020) Genetic factors associated with enhanced bla KPC expression in Tn3\/Tn4401 chimeras. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01836-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4252_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.micpath.2018.04.004","volume":"119","author":"KE Hussein","year":"2018","unstructured":"Hussein KE, Bahey-El-Din M, Sheweita SA (2018) Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model. Microb Pathog 119:12\u201318. https:\/\/doi.org\/10.1016\/j.micpath.2018.04.004","journal-title":"Microb Pathog"},{"key":"4252_CR57","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1093\/jac\/dkz228","volume":"74","author":"T Idowu","year":"2019","unstructured":"Idowu T, Ammeter D, Arthur G, Zhanel GG, Schweizer F (2019) Potentiation of \u03b2-lactam antibiotics and \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin-cyclam conjugates. J Antimicrob Chemother 74:2640\u20132648. https:\/\/doi.org\/10.1093\/jac\/dkz228","journal-title":"J Antimicrob Chemother"},{"key":"4252_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127575","author":"T Idowu","year":"2020","unstructured":"Idowu T, Ammeter D, Brizuela M, Jackson G, Alam S, Schweizer F (2020) Overcoming \u03b2-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants. Bioorg Med Chem Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127575","journal-title":"Bioorg Med Chem Lett"},{"key":"4252_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cll.2017.01.005","volume":"37","author":"A Iovleva","year":"2017","unstructured":"Iovleva A, Doi Y (2017) Carbapenem-resistant enterobacteriaceae. Clin Lab Med 37:303\u2013315","journal-title":"Clin Lab Med"},{"key":"4252_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2024.102028","author":"F Jamil","year":"2024","unstructured":"Jamil F, Khan K, Zahra N, Uddin R (2024) Lysine metabolism pathway as a target for drug repurposing: in silico approach against carbapenem-resistant Klebsiella pneumoniae. Gene Rep. https:\/\/doi.org\/10.1016\/j.genrep.2024.102028","journal-title":"Gene Rep"},{"key":"4252_CR61","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5483\/BMBRep.2023-0070","volume":"56","author":"S Jang","year":"2023","unstructured":"Jang S (2023) AcrAB-TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanism. BMB Rep 56:326\u2013334","journal-title":"BMB Rep"},{"key":"4252_CR62","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1007\/s10311-021-01274-z","volume":"19","author":"KU Jansen","year":"2021","unstructured":"Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS (2021) The impact of human vaccines on bacterial antimicrobial resistance. A review. Environ Chem Lett 19:4031\u20134062","journal-title":"Environ Chem Lett"},{"key":"4252_CR63","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.tips.2018.03.007","volume":"39","author":"LC Ju","year":"2018","unstructured":"Ju LC, Cheng Z, Fast W, Bonomo RA, Crowder MW (2018) The continuing challenge of metallo-\u03b2-lactamase inhibition: mechanism matters. Trends Pharmacol Sci 39:635\u2013647","journal-title":"Trends Pharmacol Sci"},{"key":"4252_CR64","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s10822-012-9611-9","volume":"26","author":"O Kalid","year":"2012","unstructured":"Kalid O, Toledo Warshaviak D, Shechter S, Sherman W, Shacham S (2012) Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors. J Comput Aided Mol des 26:1217\u20131228. https:\/\/doi.org\/10.1007\/s10822-012-9611-9","journal-title":"J Comput Aided Mol des"},{"key":"4252_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202300355","author":"D Kang","year":"2024","unstructured":"Kang D, Bagchi D, Chen IA (2024) Pharmacokinetics and biodistribution of phages and their current applications in antimicrobial therapy. Adv Ther (Weinh). https:\/\/doi.org\/10.1002\/adtp.202300355","journal-title":"Adv Ther (Weinh)"},{"key":"4252_CR66","doi-asserted-by":"crossref","unstructured":"Kapoor S, Bharadvaja N (2023) Virtual screening and molecular docking analysis of phytochemicals derived from woodfordia fruticosa to delineate acinetobacter baumannii OXA-23 antagonists. In: Proceedings of international conference on computational intelligence and sustainable engineering solution, CISES 2023. Institute of Electrical and Electronics Engineers Inc., pp 301\u2013305","DOI":"10.1109\/CISES58720.2023.10183389"},{"key":"4252_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fpubh.2019.00151","volume":"7","author":"I Karaiskos","year":"2019","unstructured":"Karaiskos I, Lagou S, Pontikis K, Rapti V, Poulakou G (2019) The \u201cOld\u201d and the \u201cNew\u201d antibiotics for MDR Gram-negative pathogens: for whom, when, and how. Front Public Health 7:151","journal-title":"Front Public Health"},{"key":"4252_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/mgen.0.000474","volume":"6","author":"K Kopotsa","year":"2020","unstructured":"Kopotsa K, Mbelle NM, Sekyere JO (2020) Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistant klebsiella pneumoniae clinical strains. Microb Genom 6:1\u201319. https:\/\/doi.org\/10.1099\/mgen.0.000474","journal-title":"Microb Genom"},{"key":"4252_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright KE, Chan BK, Koff JL, Turner PE (2019) Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25:219\u2013232","journal-title":"Cell Host Microbe"},{"key":"4252_CR70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12223-021-00908-7","volume":"67","author":"EO K\u00f6se","year":"2022","unstructured":"K\u00f6se EO (2022) In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae. Folia Microbiol (Praha) 67:143\u2013156. https:\/\/doi.org\/10.1007\/s12223-021-00908-7","journal-title":"Folia Microbiol (Praha)"},{"key":"4252_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2019.100020","author":"E Kousouli","year":"2019","unstructured":"Kousouli E, Zarkotou O, Polimeri K, Themeli-Digalaki K, Pournaras S (2019) Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay. Infect Prevent Pract. https:\/\/doi.org\/10.1016\/j.infpip.2019.100020","journal-title":"Infect Prevent Pract"},{"key":"4252_CR72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jointm.2023.11.007","volume":"4","author":"TO Kuloglu","year":"2024","unstructured":"Kuloglu TO, Unuvar GK, Cevahir F, Kilic AU, Alp E (2024) Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units. J Intensive Med 4:347\u2013354. https:\/\/doi.org\/10.1016\/j.jointm.2023.11.007","journal-title":"J Intensive Med"},{"key":"4252_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.banm.2019.02.007","volume":"203","author":"Y Lacotte","year":"2019","unstructured":"Lacotte Y, Francois B, Brun-Buisson C, Jouvin-Marche E, Ploy MC (2019) Research on antibacterial strategies: New tracks and challenges? Bull Acad Natl Med 203:179\u2013185. https:\/\/doi.org\/10.1016\/j.banm.2019.02.007","journal-title":"Bull Acad Natl Med"},{"key":"4252_CR74","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/jcm8070958","volume":"8","author":"CC Lai","year":"2019","unstructured":"Lai CC, Cheng IL, Chen YH, Tang HJ (2019) The efficacy and safety of doripenem in the treatment of acute bacterial infections\u2014a systemic review and meta-analysis of randomized controlled trials. J Clin Med 8:958","journal-title":"J Clin Med"},{"key":"4252_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4401829","author":"DC Lekha","year":"2021","unstructured":"Lekha DC, Shanmugam R, Madhuri K, Dwarampudi LP, Bhaskaran M, Kongara D, Tesfaye JL, Nagaprasad N, Bhargavi VLN, Krishnaraj R (2021) Review on silver nanoparticle synthesis method, antibacterial activity, drug delivery vehicles, and toxicity pathways: recent advances and future aspects. J Nanomater. https:\/\/doi.org\/10.1155\/2021\/4401829","journal-title":"J Nanomater"},{"key":"4252_CR76","first-page":"134","volume":"27","author":"JS Lim","year":"2024","unstructured":"Lim JS, Chai YY, Ser WX, Van Haeren A, Lim YH, Raja T, Foo JB, Hamzah S, Sellappans R, Yow HY (2024) Novel drug candidates against antibiotic-resistant microorganisms: a review. Iran J Basic Med Sci 27:134\u2013150","journal-title":"Iran J Basic Med Sci"},{"key":"4252_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01532","author":"W Liu","year":"2020","unstructured":"Liu W, Wu Z, Mao C, Guo G, Zeng Z, Fei Y, Wan S, Peng J, Wu J (2020) Antimicrobial peptide Cec4 eradicates the bacteria of clinical carbapenem-resistant Acinetobacter baumannii biofilm. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.01532","journal-title":"Front Microbiol"},{"key":"4252_CR78","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA (2017) The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215:S28\u2013S36. https:\/\/doi.org\/10.1093\/infdis\/jiw282","journal-title":"J Infect Dis"},{"key":"4252_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa054","author":"M L\u00f3pez-Siles","year":"2021","unstructured":"L\u00f3pez-Siles M, Corral-Lugo A, McConnell MJ (2021) Vaccines for multidrug resistant gram negative bacteria: lessons from the past for guiding future success. FEMS Microbiol Rev. https:\/\/doi.org\/10.1093\/femsre\/fuaa054","journal-title":"FEMS Microbiol Rev"},{"key":"4252_CR80","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1093\/jac\/dku151","volume":"69","author":"J Lora-Tamayo","year":"2014","unstructured":"Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo X, Yu HY, Ariza J, Li J (2014) Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant pseudomonas aeruginosa in an in vitro dynamic biofilm model. J Antimicrob Chemother 69:2434\u20132442. https:\/\/doi.org\/10.1093\/jac\/dku151","journal-title":"J Antimicrob Chemother"},{"key":"4252_CR81","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/antibiotics10070769","volume":"10","author":"G Luci","year":"2021","unstructured":"Luci G, Mattioli F, Falcone M, Di Paolo A (2021) Pharmacokinetics of non-\u03b2-lactam \u03b2-lactamase inhibitors. Antibiotics 10:769","journal-title":"Antibiotics"},{"key":"4252_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104960","author":"X Luo","year":"2021","unstructured":"Luo X, Ye X, Ding L, Zhu W, Zhao Z, Luo D, Liu N, Sun L, Chen Z (2021) Identification of the scorpion venom-derived antimicrobial peptide Hp1404 as a new antimicrobial agent against carbapenem-resistant Acinetobacter baumannii. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2021.104960","journal-title":"Microb Pathog"},{"key":"4252_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101358","author":"M \u0141usiak-Szelachowska","year":"2022","unstructured":"\u0141usiak-Szelachowska M, Mi\u0119dzybrodzki R, Rog\u00f3\u017c P, Weber-D\u0105browska B, \u017baczek M, G\u00f3rski A (2022) Do anti-phage antibodies persist after phage therapy? A preliminary report. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11101358","journal-title":"Antibiotics"},{"key":"4252_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11503-3","author":"B Ma","year":"2019","unstructured":"Ma B, Fang C, Lu L, Wang M, Xue X, Zhou Y, Li M, Hu Y, Luo X, Hou Z (2019) The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-\u03b2-lactamase. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-11503-3","journal-title":"Nat Commun"},{"key":"4252_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127249","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, Zhang W, Zhang Y, Shen A, Sun H, Li L (2023a) Global spread of carbapenem-resistant enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. https:\/\/doi.org\/10.1016\/j.micres.2022.127249","journal-title":"Microbiol Res"},{"key":"4252_CR86","doi-asserted-by":"publisher","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, Zhang W, Zhang Y, Shen A, Sun H, Li L (2023b) Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res 266:127249","journal-title":"Microbiol Res"},{"key":"4252_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09256-6","author":"JW Maina","year":"2024","unstructured":"Maina JW, Mutua JM, Musyoki AM (2024) Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-024-09256-6","journal-title":"BMC Infect Dis"},{"key":"4252_CR88","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s10103-019-02773-w","volume":"34","author":"M Marcolan De Mello","year":"2019","unstructured":"Marcolan De Mello M, De Barros PP, de Cassia BR, Alves SR, Ramanzini NP, Figueiredo-Godoi LMA, Prado ACC, Jorge AOC, Junqueira JC (2019) Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii. Lasers Med Sci 34:1755\u20131761. https:\/\/doi.org\/10.1007\/s10103-019-02773-w","journal-title":"Lasers Med Sci"},{"key":"4252_CR89","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1056\/nejmp1802256","volume":"378","author":"HD Marston","year":"2018","unstructured":"Marston HD, Paules CI, Fauci AS (2018) Monoclonal antibodies for emerging infectious diseases\u2014borrowing from history. N Engl J Med 378:1469\u20131472. https:\/\/doi.org\/10.1056\/nejmp1802256","journal-title":"N Engl J Med"},{"key":"4252_CR90","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.bbamem.2019.05.008","volume":"1861","author":"M Martinez","year":"2019","unstructured":"Martinez M, Gon\u00e7alves S, Fel\u00edcio MR, Maturana P, Santos NC, Semorile L, Hollmann A, Maff\u00eda PC (2019) Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa. Biochim Biophys Acta Biomembr 1861:1329\u20131337. https:\/\/doi.org\/10.1016\/j.bbamem.2019.05.008","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4252_CR91","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00330-24","author":"M Mateu-Borr\u00e1s","year":"2024","unstructured":"Mateu-Borr\u00e1s M, Dublin SR, Kang J, Monroe HL, Sen-Kilic E, Miller SJ, Witt WT, Chapman JA, Pyles GM, Nallar SC, Huckaby AB, Yang E, Rocuskie-Marker C, Grund ME, Amin MS, Lukomski S, Snyder GA, Ray K, Lewis GK, Ricke DO, Damron FH, Barbier M (2024) Novel broadly reactive monoclonal antibody protects against Pseudomonas aeruginosa infection. Infect Immun. https:\/\/doi.org\/10.1128\/iai.00330-24","journal-title":"Infect Immun"},{"key":"4252_CR92","doi-asserted-by":"publisher","first-page":"48813","DOI":"10.1007\/s11356-024-34436-x","volume":"31","author":"M M\u0119cik","year":"2024","unstructured":"M\u0119cik M, Stefaniak K, Harnisz M, Korzeniewska E (2024) Hospital and municipal wastewater as a source of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in the environment: a review. Environ Sci Pollut Res 31:48813\u201348838","journal-title":"Environ Sci Pollut Res"},{"key":"4252_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107380","author":"A Mehmood","year":"2020","unstructured":"Mehmood A, Naseer S, Ali A, Fatimah H, Rehman S, Kiani A (2020) Identification of novel vaccine candidates against carbapenem resistant Klebsiella pneumoniae: a systematic reverse proteomic approach. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107380","journal-title":"Comput Biol Chem"},{"key":"4252_CR94","first-page":"15","volume":"3","author":"G Meletis","year":"2016","unstructured":"Meletis G (2016) Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis 3:15\u201321","journal-title":"Ther Adv Infect Dis"},{"key":"4252_CR95","doi-asserted-by":"publisher","DOI":"10.2174\/157340911795677602","author":"X-Y Meng","year":"2011","unstructured":"Meng X-Y, Zhang H-X, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug des. https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug des"},{"key":"4252_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102127","author":"JM Mitchell","year":"2022","unstructured":"Mitchell JM, June CM, Baggett VL, Lowe BC, Ruble JF, Bonomo RA, Leonard DA, Powers RA (2022) Conformational flexibility in carbapenem hydrolysis drives substrate specificity of the class D carbapenemase OXA-24\/40. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2022.102127","journal-title":"J Biol Chem"},{"key":"4252_CR97","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2014","author":"M Monaco","year":"2013","unstructured":"Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Rossolini GM (2013) Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.es2014","journal-title":"Euro Surveill"},{"key":"4252_CR98","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1039\/D1MD00200G","volume":"12","author":"M Mora-Ochomogo","year":"2021","unstructured":"Mora-Ochomogo M, Lohans CT (2021) \u03b2-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates. RSC Med Chem 12:1623\u20131639","journal-title":"RSC Med Chem"},{"key":"4252_CR99","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere","author":"MP Motley","year":"2017","unstructured":"Motley MP, Fries BC (2017) A new take on an old remedy: generating antibodies against multidrug-resistant gram-negative bacteria in a postantibiotic world. mSphere. https:\/\/doi.org\/10.1128\/mSphere","journal-title":"mSphere"},{"key":"4252_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02059-20","volume":"11","author":"MP Motley","year":"2020","unstructured":"Motley MP, Diago-Navarro E, Banerjee K, Inzerillo S, Fries BC (2020) The role of igg subclass in antibody-mediated protection against carbapenem-resistant klebsiella pneumoniae. Mbio 11:1\u201316. https:\/\/doi.org\/10.1128\/mBio.02059-20","journal-title":"Mbio"},{"key":"4252_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00539","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.00539","journal-title":"Front Microbiol"},{"key":"4252_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011379","author":"LP Mullins","year":"2023","unstructured":"Mullins LP, Mason E, Winter K, Sadarangani M (2023) Vaccination is an integral strategy to combat antimicrobial resistance. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1011379","journal-title":"PLoS Pathog"},{"key":"4252_CR104","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biochi.2020.10.005","volume":"180","author":"TN Navien","year":"2021","unstructured":"Navien TN, Thevendran R, Hamdani HY, Tang TH, Citartan M (2021) In silico molecular docking in DNA aptamer development. Biochimie 180:54\u201367","journal-title":"Biochimie"},{"key":"4252_CR105","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1111\/jam.15130","volume":"131","author":"M Nguyen","year":"2021","unstructured":"Nguyen M, Joshi SG (2021) Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. J Appl Microbiol 131:2715\u20132738","journal-title":"J Appl Microbiol"},{"key":"4252_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2024.101184","author":"SE Ogbodo","year":"2024","unstructured":"Ogbodo SE, Edeghor OU, Benson CU, Ajaba MO, Godfrey OC, Gulack AO, Ibrahim AG, Ibrahim AJ, Joshua G, Chinweokwu UJ (2024) Computational investigation of amide derivative as potential anti-carbapenem-resistant Pseudomonas aeruginosa. J Indian Chem Soc. https:\/\/doi.org\/10.1016\/j.jics.2024.101184","journal-title":"J Indian Chem Soc"},{"key":"4252_CR107","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/jam.14388","volume":"127","author":"A Pal","year":"2019","unstructured":"Pal A, Tripathi A (2019) Quercetin potentiates meropenem activity among pathogenic carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. J Appl Microbiol 127:1038\u20131047. https:\/\/doi.org\/10.1111\/jam.14388","journal-title":"J Appl Microbiol"},{"key":"4252_CR108","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cmi.2018.01.015","volume":"10","author":"L Papst","year":"2018","unstructured":"Papst L, Beovi\u0107 B, Pulcini C, Durante-Mangoni E, Rodr\u00edguez-Ba\u00f1o J, Kaye KS, Daikos GL, Raka L, Paul M (2018) Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect 10:1070\u20131076. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.015","journal-title":"Clin Microbiol Infect"},{"key":"4252_CR109","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/1874285801812010288","volume":"12","author":"SG Pereira","year":"2018","unstructured":"Pereira SG, Domingues VS, Theri\u00e1ga J, Chasqueira MJ, Paix\u00e3o P (2018) Non-antimicrobial drugs: etodolac as a possible antimicrobial or adjuvant agent against ESKAPE pathogens. Open Microbiol J 12:288\u2013296. https:\/\/doi.org\/10.2174\/1874285801812010288","journal-title":"Open Microbiol J"},{"key":"4252_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2024.105347","author":"IL Pereira","year":"2024","unstructured":"Pereira IL, Cardoso TL, Wozeak DR, Caballero PS, Buchhorn de Freitas S, Pinto Seixas Neto AC, da Silva PL, Hartwig DD (2024) Antibodies anti-rFilF protein has anti-biofilm activity against carbapenem-resistant Acinetobacter baumannii. Microbes Infect. https:\/\/doi.org\/10.1016\/j.micinf.2024.105347","journal-title":"Microbes Infect"},{"key":"4252_CR111","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.diagmicrobio.2019.01.020","volume":"94","author":"AM Peri","year":"2019","unstructured":"Peri AM, Doi Y, Potoski BA, Harris PNA, Paterson DL, Righi E (2019) Antimicrobial treatment challenges in the era of carbapenem resistance. Diagn Microbiol Infect Dis 94:413\u2013425","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4252_CR112","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","volume":"5","author":"A Petrovic Fabijan","year":"2020","unstructured":"Petrovic Fabijan A, Lin RCY, Ho J, Maddocks S, Ben Zakour NL, Iredell JR, Khalid A, Venturini C, Chard R, Morales S, Sandaradura I, Gilbey T (2020) Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol 5:465\u2013472. https:\/\/doi.org\/10.1038\/s41564-019-0634-z","journal-title":"Nat Microbiol"},{"key":"4252_CR113","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi L, Rastelli G (2019) Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci 20:4331","journal-title":"Int J Mol Sci"},{"key":"4252_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010070","author":"L Qiao","year":"2024","unstructured":"Qiao L, Zhang Y, Chen Y, Chi X, Ding J, Zhang H, Han Y, Zhang B, Jiang J, Lin Y (2024) synergistic activity and mechanism of sanguinarine with polymyxin B against gram-negative bacterial infections. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16010070","journal-title":"Pharmaceutics"},{"key":"4252_CR115","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/IDR.S357746","volume":"15","author":"J Qu","year":"2022","unstructured":"Qu J, Qi TT, Qu Q, Long WM, Chen Y, Luo Y, Wang Y (2022) Polymyxin B-based regimens for patients infected with carbapenem-resistant gram-negative bacteria: clinical and microbiological efficacy, mortality, and safety. Infect Drug Resist 15:1205\u20131218. https:\/\/doi.org\/10.2147\/IDR.S357746","journal-title":"Infect Drug Resist"},{"key":"4252_CR116","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/1462-2920.15930","volume":"24","author":"WT Ramaloko","year":"2022","unstructured":"Ramaloko WT, Osei Sekyere J (2022) Phylogenomics, epigenomics, virulome and mobilome of Gram-negative bacteria co-resistant to carbapenems and polymyxins: a One Health systematic review and meta-analyses. Environ Microbiol 24:1518\u20131542. https:\/\/doi.org\/10.1111\/1462-2920.15930","journal-title":"Environ Microbiol"},{"key":"4252_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24163-z","author":"F Ramezanalizadeh","year":"2022","unstructured":"Ramezanalizadeh F, Rasooli I, Owlia P, Darvish Alipour Astaneh S, Abdolhamidi R (2022) Vaccination with a combination of planktonic and biofilm virulence factors confers protection against carbapenem-resistant Acinetobacter baumannii strains. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-24163-z","journal-title":"Sci Rep"},{"key":"4252_CR118","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00074-19","author":"S Ranjitkar","year":"2019","unstructured":"Ranjitkar S, Reck F, Ke X, Zhu Q, McEnroe G, Lopez SL, Dean CR (2019) Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry bla NDM-1. mSphere. https:\/\/doi.org\/10.1128\/msphere.00074-19","journal-title":"mSphere"},{"key":"4252_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2024.101935","author":"A Raza","year":"2024","unstructured":"Raza A, Mushtaq N, Jabbar A, El-Sayed Ellakwa D (2024) Antimicrobial peptides: a promising solution to combat colistin and carbapenem resistance. Gene Rep. https:\/\/doi.org\/10.1016\/j.genrep.2024.101935","journal-title":"Gene Rep"},{"key":"4252_CR120","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/nejmoa1602615","volume":"70","author":"J Rounds","year":"2017","unstructured":"Rounds J, Strain J (2017) Bezlotoxumab for preventing recurrent clostridium difficile infections. S D Med 70:422\u2013423. https:\/\/doi.org\/10.1056\/nejmoa1602615","journal-title":"S D Med"},{"key":"4252_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.12.032","author":"S Roy","year":"2022","unstructured":"Roy S, Hazra S, Basu S (2022) Establishing the role of novel mutations within AdeRS using homology modelling that cause carbapenem resistance in Acinetobacter baumannii and study the binding patterns of AdeABC with carbapenems and PA\u03b2N using molecular docking. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2021.12.032","journal-title":"Int J Infect Dis"},{"key":"4252_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.628144","author":"BM Sahoo","year":"2021","unstructured":"Sahoo BM, Ravi Kumar BVV, Sruti J, Mahapatra MK, Banik BK, Borah P (2021) Drug repurposing strategy (DRS): emerging approach to identify potential therapeutics for treatment of novel coronavirus infection. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.628144","journal-title":"Front Mol Biosci"},{"key":"4252_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1089140","author":"F Salv\u00e0-Serra","year":"2023","unstructured":"Salv\u00e0-Serra F, Ja\u00e9n-Luchoro D, Marathe NP, Adlerberth I, Moore ERB, Karlsson R (2023) Responses of carbapenemase-producing and non-producing carbapenem-resistant Pseudomonas aeruginosa strains to meropenem revealed by quantitative tandem mass spectrometry proteomics. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.1089140","journal-title":"Front Microbiol"},{"key":"4252_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antibiotics5010012","volume":"5","author":"E Sauvage","year":"2016","unstructured":"Sauvage E, Terrak M (2016) Glycosyltransferases and transpeptidases\/penicillin-binding proteins: valuable targets for new antibacterials. Antibiotics 5:12","journal-title":"Antibiotics"},{"key":"4252_CR125","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/antibiotics13060506","volume":"13","author":"F Serapide","year":"2024","unstructured":"Serapide F, Guastalegname M, Gull\u00ec SP, Lionello R, Bruni A, Garofalo E, Longhini F, Trecarichi EM, Russo A (2024) Antibiotic treatment of carbapenem-resistant acinetobacter baumannii infections in view of the newly developed \u03b2-lactams: a narrative review of the existing evidence. Antibiotics 13:506","journal-title":"Antibiotics"},{"key":"4252_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics5030030","author":"MS Setzer","year":"2016","unstructured":"Setzer MS, Sharifi-Rad J, Setzer WN (2016) The search for herbal antibiotics: an in-silico investigation of antibacterial phytochemicals. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics5030030","journal-title":"Antibiotics"},{"key":"4252_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119525","author":"A S\u0142oczy\u0144ska","year":"2023","unstructured":"S\u0142oczy\u0144ska A, Wand ME, Bock LJ, Tyski S, Laudy AE (2023) Efflux-related carbapenem resistance in acinetobacter baumannii is associated with two-component regulatory efflux systems\u2019 alteration and insertion of \u0394AbaR25-type island fragment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119525","journal-title":"Int J Mol Sci"},{"key":"4252_CR128","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00430-23","author":"Y-Q Song","year":"2023","unstructured":"Song Y-Q, Kyung SM, Kim S, Kim G, Lee SY, Yoo HS (2023) Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant Pseudomonas aeruginosa. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.00430-23","journal-title":"Microbiol Spectr"},{"key":"4252_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1426603","author":"Y Song","year":"2024","unstructured":"Song Y, Zou Y, Xu L, Wang J, Deng X, Zhou Y, Li D (2024) Ginkgolic Acid as a carbapenem synergist against KPC-2 positive Klebsiella pneumoniae. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1426603","journal-title":"Front Microbiol"},{"key":"4252_CR130","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10822-018-0182-2","volume":"33","author":"F Spyrakis","year":"2019","unstructured":"Spyrakis F, Bellio P, Quotadamo A, Linciano P, Benedetti P, D\u2019Arrigo G, Baroni M, Cendron L, Celenza G, Tondi D (2019) First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase. J Comput Aided Mol des 33:295\u2013305. https:\/\/doi.org\/10.1007\/s10822-018-0182-2","journal-title":"J Comput Aided Mol des"},{"key":"4252_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69431-y","author":"F Spyrakis","year":"2020","unstructured":"Spyrakis F, Santucci M, Maso L, Cross S, Gianquinto E, Sannio F, Verdirosa F, De Luca F, Docquier JD, Cendron L, Tondi D, Venturelli A, Cruciani G, Costi MP (2020) Virtual screening identifies broad-spectrum \u03b2-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-69431-y","journal-title":"Sci Rep"},{"key":"4252_CR132","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, Aboderin AO, Al-Abri SS, Awang Jalil N, Benzonana N, Bhattacharya S, Brink AJ, Burkert FR, Cars O, Cornaglia G, Dyar OJ, Friedrich AW, Gales AC, Gandra S, Giske CG, Goff DA, Goossens H, Gottlieb T, Guzman Blanco M, Hryniewicz W, Kattula D, Jinks T, Kanj SS, Kerr L, Kieny MP, Kim YS, Kozlov RS, Labarca J, Laxminarayan R, Leder K, Leibovici L, Levy-Hara G, Littman J, Malhotra-Kumar S, Manchanda V, Moja L, Ndoye B, Pan A, Paterson DL, Paul M, Qiu H, Ramon-Pardo P, Rodr\u00edguez-Ba\u00f1o J, Sanguinetti M, Sengupta S, Sharland M, Si-Mehand M, Silver LL, Song W, Steinbakk M, Thomsen J, Thwaites GE, van der Meer JW, Van Kinh N, Vega S, Villegas MV, Wechsler-F\u00f6rd\u00f6s A, Wertheim HFL, Wesangula E, Woodford N, Yilmaz FO, Zorzet A (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318\u2013327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"key":"4252_CR133","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01140-18","author":"PD Tamma","year":"2018","unstructured":"Tamma PD, Simner PJ (2018) Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.01140-18","journal-title":"J Clin Microbiol"},{"key":"4252_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10081023","author":"P Terbtothakun","year":"2021","unstructured":"Terbtothakun P, Nwabor OF, Siriyong T, Voravuthikunchai SP, Chusri S (2021) Synergistic antibacterial effects of meropenem in combination with aminoglycosides against carbapenem-resistant escherichia coli harboring blaNDM-1 and blaNDM-5. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics10081023","journal-title":"Antibiotics"},{"key":"4252_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040749","author":"CH Tseng","year":"2023","unstructured":"Tseng CH, Huang YT, Mao YC, Lai CH, Yeh TK, Ho CM, Liu PY (2023) Insight into the mechanisms of carbapenem resistance in Klebsiella pneumoniae: a study on IS26 integrons, beta-lactamases, porin modifications, and plasmidome analysis. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics12040749","journal-title":"Antibiotics"},{"key":"4252_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2020.101882","author":"M Valenzuela-Valderrama","year":"2020","unstructured":"Valenzuela-Valderrama M, Carrasco-V\u00e9liz N, Gonz\u00e1lez IA, Dreyse P, Erick Palavecino C (2020) Synergistic effect of combined imipenem and photodynamic treatment with the cationic Ir(III) complexed to polypyridine ligand on carbapenem-resistant Klebsiella pneumoniae. Photodiagnosis Photodyn Ther. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101882","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4252_CR137","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4230788","author":"A Vasudevan","year":"2022","unstructured":"Vasudevan A, Kesavan DK, Wu L, Su Z, Wang S, Ramasamy MK, Hopper W, Xu H (2022) In Silico and in Vitro Screening of Natural Compounds as Broad-Spectrum \u03b2-Lactamase Inhibitors against Acinetobacter baumannii New Delhi Metallo-\u03b2-lactamase-1 (NDM-1). Biomed Res Int. https:\/\/doi.org\/10.1155\/2022\/4230788","journal-title":"Biomed Res Int"},{"key":"4252_CR138","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41579-019-0294-2","volume":"18","author":"J Vergalli","year":"2020","unstructured":"Vergalli J, Bodrenko IV, Masi M, Moyni\u00e9 L, Acosta-Guti\u00e9rrez S, Naismith JH, Davin-Regli A, Ceccarelli M, van den Berg B, Winterhalter M, Pag\u00e8s JM (2020) Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria. Nat Rev Microbiol 18:164\u2013176","journal-title":"Nat Rev Microbiol"},{"key":"4252_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104766","author":"P Verma","year":"2021","unstructured":"Verma P, Tiwari M, Tiwari V (2021) Efflux pumps in multidrug-resistant Acinetobacter baumannii: current status and challenges in the discovery of efflux pumps inhibitors. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2021.104766","journal-title":"Microb Pathog"},{"key":"4252_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00426","author":"G Vukotic","year":"2020","unstructured":"Vukotic G, Obradovic M, Novovic K, Di Luca M, Jovcic B, Fira D, Neve H, Kojic M, McAuliffe O (2020) Characterization, antibiofilm, and depolymerizing activity of two phages active on carbapenem-resistant Acinetobacter baumannii. Front Med. https:\/\/doi.org\/10.3389\/fmed.2020.00426","journal-title":"Front Med"},{"key":"4252_CR141","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5720417","author":"J Wang","year":"2018","unstructured":"Wang J, He JT, Bai Y, Wang R, Cai Y (2018) Synergistic activity of colistin\/fosfomycin combination against carbapenemase-producing Klebsiella pneumoniae in an in vitro pharmacokinetic\/pharmacodynamic model. Biomed Res Int. https:\/\/doi.org\/10.1155\/2018\/5720417","journal-title":"Biomed Res Int"},{"key":"4252_CR142","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","volume":"22","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang J, Wang R, Cai Y (2020a) Resistance to ceftazidime\u2013avibactam and underlying mechanisms. J Glob Antimicrob Resist 22:18\u201327","journal-title":"J Glob Antimicrob Resist"},{"key":"4252_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103567","author":"X Wang","year":"2020","unstructured":"Wang X, Yang Y, Gao Y, Niu X (2020b) Discovery of the novel inhibitor against New Delhi metallo-\u03b2-lactamase based on virtual screening and molecular modelling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21103567","journal-title":"Int J Mol Sci"},{"key":"4252_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08339-0","author":"J Wang","year":"2023","unstructured":"Wang J, Shah BK, Zhao J, Xiong J, Wang C, Xie S (2023) Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-023-08339-0","journal-title":"BMC Infect Dis"},{"key":"4252_CR145","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01882-23","author":"S Wang","year":"2024","unstructured":"Wang S, Tan X, Liu Z, Ma H, Liu T, Yang Y, Ying Y, Gao R, Zhang D, Ma Y, Chen K, Lin L, Jiang Z, Yu J (2024) Pharmacokinetics and safety evaluation of intravenously administered Pseudomonas phage PA_LZ7 in a mouse model. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.01882-23","journal-title":"Microbiol Spectr"},{"key":"4252_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1419989","author":"Y Wei","year":"2024","unstructured":"Wei Y, Xin X, Zhang J, Liao Q, Rong Y, Zhong Y, Zhao M, Ma J, He S (2024) Genome-wide sRNA and mRNA transcriptomic profiling insights into carbapenem-resistant Acinetobacter baumannii. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2024.1419989","journal-title":"Front Cell Infect Microbiol"},{"key":"4252_CR147","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","volume":"24","author":"GD Wright","year":"2016","unstructured":"Wright GD (2016) Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol 24:862\u2013871","journal-title":"Trends Microbiol"},{"key":"4252_CR148","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40121-021-00411-z","volume":"10","author":"D Wu","year":"2021","unstructured":"Wu D, Chen C, Liu T, Jia Y, Wan Q, Peng J (2021) Epidemiology, susceptibility, and risk factors associated with mortality in carbapenem-resistant gram-negative bacterial infections among abdominal solid organ transplant recipients: a retrospective cohort study. Infect Dis Ther 10:559\u2013573. https:\/\/doi.org\/10.1007\/s40121-021-00411-z","journal-title":"Infect Dis Ther"},{"key":"4252_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00195","author":"L Yang","year":"2020","unstructured":"Yang L, Lin Y, Lu L, Xue M, Ma H, Guo X, Wang K, Li P, Du X, Qi K, Li P, Song H (2020) Coexistence of two blaNDM\u20135 genes carried on IncX3 and IncFII plasmids in an Escherichia coli isolate revealed by illumina and nanopore sequencing. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.00195","journal-title":"Front Microbiol"},{"key":"4252_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107106","author":"L Yang","year":"2024","unstructured":"Yang L, Gao Y, Zhang J, Tian C, Lin F, Song D, Zhou L, Peng J, Guo G (2024) Antimicrobial peptide DvAMP combats carbapenem-resistant Acinetobacter baumannii infection. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107106","journal-title":"Int J Antimicrob Agents"},{"key":"4252_CR151","doi-asserted-by":"publisher","first-page":"2396877","DOI":"10.1080\/22221751.2024.2396877","volume":"13","author":"Y Yao","year":"2024","unstructured":"Yao Y, Lei T, Gao J, Xu Q, Xu L, Zhao B, Qin S, Yu Y, Hua X (2024) Discovery of novel BfmR inhibitors restoring carbapenem susceptibility against carbapenem-resistant Acinetobacter baumannii by structure-based virtual screening and biological evaluation. Emerg Microbes Infect 13:2396877. https:\/\/doi.org\/10.1080\/22221751.2024.2396877","journal-title":"Emerg Microbes Infect"},{"issue":"28","key":"4252_CR101","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","volume":"21","author":"W Younis","year":"2015","unstructured":"Younis W, Thangamani S, Seleem MN (2015) Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections. Curr Pharm Des 21(28):4106-4111. https:\/\/doi.org\/10.2174\/1381612821666150506154434","journal-title":"Curr Pharm Des"},{"key":"4252_CR152","doi-asserted-by":"publisher","first-page":"1452.e1","DOI":"10.1016\/J.CMI.2023.07.030","volume":"29","author":"R Yu","year":"2023","unstructured":"Yu R, Li L, Zou C, Chen Z, Schwarz S, Chen S, Xu C, Yao H, Du XD (2023) Emergence of high-level tigecycline resistance due to the amplification of a tet(A) gene variant in clinical carbapenem-resistant Klebsiella pneumoniae. Clin Microbiol Infect 29:1452.e1-1452.e7. https:\/\/doi.org\/10.1016\/J.CMI.2023.07.030","journal-title":"Clin Microbiol Infect"},{"key":"4252_CR153","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jmr.2471","volume":"28","author":"E Yuriev","year":"2015","unstructured":"Yuriev E, Holien J, Ramsland PA (2015) Improvements, trends, and new ideas in molecular docking: 2012\u20132013 in review. J Mol Recognit 28:581\u2013604","journal-title":"J Mol Recognit"},{"key":"4252_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107769","author":"L Zha","year":"2024","unstructured":"Zha L, Li S, Guo J, Hu Y, Pan L, Wang H, Zhou Y, Xu Q, Lu Z, Kong X, Tong X, Cheng Y (2024) Global and regional burden of bloodstream infections caused by carbapenem-resistant gram-negative bacteria in 2019: a systematic analysis from the MICROBE database. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2024.107769","journal-title":"Int J Infect Dis"},{"key":"4252_CR155","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s40843-022-2459-3","volume":"66","author":"X Zhao","year":"2023","unstructured":"Zhao X, Liu S, Jiang X (2023) Leveraging bimetallic nanoparticles to synergistically enhance the efficacy of antibiotics against carbapenem-resistant bacteria. Sci China Mater 66:2885\u20132892. https:\/\/doi.org\/10.1007\/s40843-022-2459-3","journal-title":"Sci China Mater"},{"key":"4252_CR156","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2366354","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Yang T, Xiang G, Zhang S, Cai Y, Zhong G, Pu J, Shen C, Zeng J, Chen C (2024) A novel small RNA PhaS contributes to polymyxin B-heteroresistance in carbapenem-resistant Klebsiella pneumoniae. Emerg Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2366354","journal-title":"Emerg Microbes Infect"},{"key":"4252_CR157","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/microorganisms11071690","volume":"11","author":"G Zhou","year":"2023","unstructured":"Zhou G, Wang Q, Wang Y, Wen X, Peng H, Peng R, Shi Q, Xie X, Li L (2023) Outer membrane porins contribute to antimicrobial resistance in gram-negative bacteria. Microorganisms 11:1690","journal-title":"Microorganisms"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04252-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T09:27:35Z","timestamp":1740994055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04252-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":157,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["4252"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04252-z","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"58"}}